Literature DB >> 15790700

Detection of BRAF mutations in colorectal tumours and peritoneal washings using a mismatch ligation assay.

K Busby1, A Morris.   

Abstract

AIMS: To detect cells bearing BRAF mutations in colorectal tumour samples and peritoneal washings, using a mismatch ligation assay (MLA).
METHODS: DNA from 46 colorectal tumours was studied. Part of exon 15 of the BRAF gene was amplified using the polymerase chain reaction, and T-->A mutations at codon 600 were detected using MLA. When a mutation was detected, the same mutation was sought in peritoneal washings from that patient.
RESULTS: BRAF mutations were detected in five of the 45 analysable tumour samples. In four cases, this result was confirmed by sequencing analysis. More tumours with BRAF mutations were Dukes' stage C or D rather than A or B (p < 0.02). Dilution experiments revealed that one mutant cell could be detected in 1000 normal cells. Cells with the same BRAF mutation were present in the peritoneal washing taken at the start of the operation in four of the five patients.
CONCLUSIONS: MLA is a suitable technique for the detection of BRAF mutations, and allows the detection of small numbers of isolated tumour cells shed from the primary tumour.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15790700      PMCID: PMC1770633          DOI: 10.1136/jcp.2004.018655

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  High gradient magnetic cell separation with MACS.

Authors:  S Miltenyi; W Müller; W Weichel; A Radbruch
Journal:  Cytometry       Date:  1990

2.  A ligase-mediated gene detection technique.

Authors:  U Landegren; R Kaiser; J Sanders; L Hood
Journal:  Science       Date:  1988-08-26       Impact factor: 47.728

3.  Detection of mitochondrial DNA alterations in primary tumors and corresponding serum of colorectal cancer patients.

Authors:  K Hibi; H Nakayama; T Yamazaki; T Takase; M Taguchi; Y Kasai; K Ito; S Akiyama; A Nakao
Journal:  Int J Cancer       Date:  2001-11-01       Impact factor: 7.396

4.  Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.

Authors:  M Sanchez-Cespedes; M Esteller; K Hibi; F O Cope; W H Westra; S Piantadosi; J G Herman; J Jen; D Sidransky
Journal:  Clin Cancer Res       Date:  1999-09       Impact factor: 12.531

5.  Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.

Authors:  Siu T Yuen; Helen Davies; Tsun L Chan; Judy W Ho; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Wendy W Tsui; Annie S Chan; P Andrew Futreal; Michael R Stratton; Richard Wooster; Suet Y Leung
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

6.  Detecting colorectal cancer in stool with the use of multiple genetic targets.

Authors:  S M Dong; G Traverso; C Johnson; L Geng; R Favis; K Boynton; K Hibi; S N Goodman; M D'Allessio; P Paty; S R Hamilton; D Sidransky; F Barany; B Levin; A Shuber; K W Kinzler; B Vogelstein; J Jen
Journal:  J Natl Cancer Inst       Date:  2001-06-06       Impact factor: 13.506

7.  Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9.

Authors:  Rajiv Kumar; Sabrina Angelini; Kari Hemminki
Journal:  Oncogene       Date:  2003-12-18       Impact factor: 9.867

8.  Molecular determinants of dysplasia in colorectal lesions.

Authors:  J Jen; S M Powell; N Papadopoulos; K J Smith; S R Hamilton; B Vogelstein; K W Kinzler
Journal:  Cancer Res       Date:  1994-11-01       Impact factor: 12.701

9.  Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status.

Authors:  Harith Rajagopalan; Alberto Bardelli; Christoph Lengauer; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Nature       Date:  2002-08-29       Impact factor: 49.962

10.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

View more
  1 in total

1.  Application of a BRAF pyrosequencing assay for mutation detection and copy number analysis in malignant melanoma.

Authors:  Cynthia Spittle; M Renee Ward; Katherine L Nathanson; Phyllis A Gimotty; Eric Rappaport; Marcia S Brose; Angelica Medina; Richard Letrero; Meenhard Herlyn; Robin H Edwards
Journal:  J Mol Diagn       Date:  2007-08-09       Impact factor: 5.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.